Civic Intelligence

Microbiome Therapeutic Innovation Group

990 • Fiscal year 2018 • EIN 82-4927284

Jan 01, 2018 to Dec 31, 2018

Washington, DC
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

47th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2018 filings • 501(c)6 • <$500k nonprofits • Source year 2018

Liabilities / Revenue

47th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2018 filings • 501(c)6 • <$500k nonprofits • Source year 2018

Net Margin

74th percentile

13%

Higher net margin than 74% of similar nonprofits.

2018 filings • 501(c)6 • <$500k nonprofits • Source year 2018

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2018

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2018

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2018

Assets

$13,661

No earlier filing loaded for comparison.

Net Assets

$13,661

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

$105,000

No earlier filing loaded for comparison.

Expenses

$91,339

No earlier filing loaded for comparison.

Net Income

$13,661

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$300K$200K$100K$0Assets 2018: $13,661Liabilities 2018: $0Net Assets 2018: $13,6612018Assets 2019: $216,705Liabilities 2019: $0Net Assets 2019: $216,7052019Assets 2020: $157,714Liabilities 2020: $0Net Assets 2020: $157,7142020Assets 2021: $207,704Liabilities 2021: $0Net Assets 2021: $207,7042021Assets 2022: $59,163Liabilities 2022: $0Net Assets 2022: $59,1632022Assets 2023: $116,253Liabilities 2023: $0Net Assets 2023: $116,2532023Assets 2024: $42,287Liabilities 2024: $0Net Assets 2024: $42,2872024

Highlighted filing

2018

Assets$13,661
Liabilities$0
Net Assets$13,661

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$600K$400K$200K$0-$200KRevenue 2018: $105,000Expenses 2018: $91,339Net Income 2018: $13,6612018Revenue 2019: $420,001Expenses 2019: $216,957Net Income 2019: $203,0442019Revenue 2020: $262,500Expenses 2020: $321,491Net Income 2020: -$58,9912020Revenue 2021: $487,464Expenses 2021: $437,474Net Income 2021: $49,9902021Revenue 2022: $394,988Expenses 2022: $543,529Net Income 2022: -$148,5412022Revenue 2023: $558,236Expenses 2023: $501,146Net Income 2023: $57,0902023Revenue 2024: $404,063Expenses 2024: $478,029Net Income 2024: -$73,9662024

Highlighted filing

2018

Revenue$105,000
Expenses$91,339
Net Income$13,661
Filing Detail Status

This 2018 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2018 to Dec 31, 2018
Mission and Program Overview

Mission

Utilize collective power to improve the regulatory, investment, and commercial environment for microbiome therapeutic and microbiome-based products.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 2018 filings • 501(c)6 • <$500k nonprofits